HK182096A - Novel calcium supplements - Google Patents

Novel calcium supplements Download PDF

Info

Publication number
HK182096A
HK182096A HK182096A HK182096A HK182096A HK 182096 A HK182096 A HK 182096A HK 182096 A HK182096 A HK 182096A HK 182096 A HK182096 A HK 182096A HK 182096 A HK182096 A HK 182096A
Authority
HK
Hong Kong
Prior art keywords
calcium
malate
calcium citrate
citrate malate
bone
Prior art date
Application number
HK182096A
Other languages
German (de)
English (en)
French (fr)
Inventor
Allen Jacobs Stephen
Original Assignee
Norwich Eaton Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Eaton Pharmaceuticals, Inc. filed Critical Norwich Eaton Pharmaceuticals, Inc.
Publication of HK182096A publication Critical patent/HK182096A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/265—Citric acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK182096A 1987-08-28 1996-10-03 Novel calcium supplements HK182096A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9081387A 1987-08-28 1987-08-28

Publications (1)

Publication Number Publication Date
HK182096A true HK182096A (en) 1996-10-11

Family

ID=22224448

Family Applications (1)

Application Number Title Priority Date Filing Date
HK182096A HK182096A (en) 1987-08-28 1996-10-03 Novel calcium supplements

Country Status (13)

Country Link
EP (1) EP0304987B1 (da)
JP (1) JP2795651B2 (da)
KR (1) KR970009583B1 (da)
AT (1) ATE82120T1 (da)
AU (1) AU625809B2 (da)
CA (1) CA1314233C (da)
DE (1) DE3875867T2 (da)
DK (1) DK481388A (da)
HK (1) HK182096A (da)
IE (1) IE61452B1 (da)
IL (1) IL87452A (da)
NZ (1) NZ225950A (da)
ZA (1) ZA886355B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2085008C (en) * 1990-06-14 1998-08-18 Mary M. Fox Calcium citrate malate composition
DE69233250T2 (de) * 1991-05-06 2004-08-26 The Procter & Gamble Company, Cincinnati Kombinationen aus calzium und vitamin d
US5389387A (en) * 1991-12-26 1995-02-14 The Procter & Gamble Company Storage stable calcium-supplemented beverage concentrates
CA2123604C (en) * 1991-12-26 1998-02-17 Alice Lyles Burkes Storage stable calcium-supplemented beverage concentrates
AU5406094A (en) * 1992-10-21 1994-05-09 Procter & Gamble Company, The Sweetener containing a concentrated bioavailable calcium source
EP0788318B1 (en) * 1992-10-21 2000-12-20 The Procter & Gamble Company Concentrated bioavailable calcium source
EP0665720B1 (en) * 1992-10-21 1996-07-10 The Procter & Gamble Company Storage stable calcium-supplemented beverage premix concentrates and syrups
IL115241A (en) * 1994-09-26 2000-08-31 American Cyanamid Co Calcium dietary supplement
JPH09173020A (ja) * 1995-12-28 1997-07-08 Shiro Tanaka クエン酸・リンゴ酸カルシウムの可溶性濃厚カルシウム凍結品／冷蔵品およびその製造法
AU2007285386B2 (en) * 2006-08-17 2011-02-03 The Procter & Gamble Company Compositions comprising calcium citrate malate and methods for making the same
EP2051701A2 (en) * 2006-08-17 2009-04-29 The Procter and Gamble Company Compositions comprising calcium citrate malate and methods for making the same
TR200908237A2 (tr) 2009-11-02 2011-05-23 Bi̇lgi̇ç Mahmut Kalsiyum ve D vitamini içeren farmasötik bileşimler.
JP2015500333A (ja) * 2011-12-13 2015-01-05 アモーフィカル リミテッド． カルシウム吸収不良及び代謝性骨障害を治療するための非晶質炭酸カルシウム
AU2016273058B2 (en) 2015-06-04 2021-05-20 Amorphical Ltd. Amorphous calcium carbonate stabilized with polyphosphates or bisphosphonates
IL266149B (en) 2016-10-25 2022-08-01 Amorphical Ltd Amorphous calcium carbonate for treating a leukemia
MX2022000947A (es) 2019-07-23 2022-04-26 Amorphical Ltd Carbonato de calcio amorfo para mejorar el rendimiento deportivo.
CN112137787B (zh) * 2020-09-16 2023-01-06 张宏伟 一种足踝外科下胫腓关节复位固定导向器

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601249A1 (fr) * 1986-07-09 1988-01-15 Sandoz Lab Nouvelles compositions pharmaceutiques a base de sels de calcium.
US4786510A (en) * 1987-07-02 1988-11-22 The Procter & Gamble Company Calcium-iron mineral supplements
CA1319612C (en) * 1987-07-02 1993-06-29 Haile Mehansho Iron-calcium mineral supplements with enhanced bioavailability

Also Published As

Publication number Publication date
NZ225950A (en) 1991-10-25
KR970009583B1 (en) 1997-06-14
AU625809B2 (en) 1992-07-16
IE61452B1 (en) 1994-11-02
IL87452A (en) 1992-07-15
ZA886355B (en) 1989-05-30
CA1314233C (en) 1993-03-09
DK481388A (da) 1989-03-02
JP2795651B2 (ja) 1998-09-10
KR890003391A (ko) 1989-04-14
JPH01156985A (ja) 1989-06-20
IL87452A0 (en) 1989-01-31
AU2159888A (en) 1989-06-15
EP0304987A2 (en) 1989-03-01
DE3875867D1 (de) 1992-12-17
IE882610L (en) 1989-02-28
EP0304987B1 (en) 1992-11-11
EP0304987A3 (en) 1990-02-21
ATE82120T1 (de) 1992-11-15
DE3875867T2 (de) 1993-04-01
DK481388D0 (da) 1988-08-29

Similar Documents

Publication Publication Date Title
EP0304987B1 (en) Novel calcium supplements
US5128374A (en) Use of calcium citrate malate for the treatment of osteoporosis and related disorders
JP3708115B2 (ja) 混合カルシウム及びビタミンｄ補給品
US5314919A (en) Calcium supplements
EP0542912B1 (en) Calcium and trace mineral supplements
AU666654B2 (en) Calcium, trace mineral, vitamin D and drug therapy combinations
US5232709A (en) Calcium and trace mineral supplements comprising estrogen
EP0304986B1 (en) The use of certain calcium-citrate-malate for the manufacture of a medicament for the treatment of osteoporosis
JPH0651626B2 (ja) 組織退行性炎症性疾患の治療用組成物
WO2010008976A2 (en) Combined calcium, magnesium and vitamin d supplements
US6287607B2 (en) Potassium calcium citrate compositions and methods therefor
KR20100107468A (ko) 골다공증을 예방 및 개선하기 위한 칼슘, 마그네슘, 아연, 및 비타민 ｄ3을 포함하는 배합물
US5905093A (en) Fish scale extract as a calcium supplement
HU211084B (en) Process for producing oral pharmaceutical composition of bone strengthening activity
JPH0840975A (ja) カルシウム−アルカリ金属クエン酸塩化合物、その製法及びこれを含有する医薬品
CA2159355C (en) Method and composition for treatment of osteoporosis
WO1999040941A1 (en) A fish scale extract as a calcium supplement
JPH09157174A (ja) カルシウム製剤
HK1006149B (en) Calcium and trace mineral supplements

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20080814